Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
The Transforming Growth Factor-β (TGF-β) signaling pathway has a well-documented, context-dependent role in breast cancer development. In normal and premalignant cells, it acts as a tumor suppressor. By contrast, during the malignant phases of breast cancer progression, the TGF-&am...
Main Authors: | Sudha Suriyamurthy, David Baker, Peter ten Dijke, Prasanna Vasudevan Iyengar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/726 |
Similar Items
-
A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
by: Linh Khanh Huynh, et al.
Published: (2019-11-01) -
Magnolol Suppresses Pancreatic Cancer Development In Vivo and In Vitro via Negatively Regulating TGF-β/Smad Signaling
by: Shuo Chen, et al.
Published: (2020-12-01) -
Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
by: Hui-Wen Yang, et al.
Published: (2023-11-01) -
On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
by: Adilson Fonseca Teixeira, et al.
Published: (2020-07-01) -
Editorial: TGF-β and BMP signaling in cancer
by: Xiaohua Yan, et al.
Published: (2022-09-01)